Extended survival observed in adoptive activated T lymphocyte immunotherapy for advanced lung cancer: results of a multicenter historical cohort study. [electronic resource]
Producer: 20130104Description: 1781-90 p. digitalISSN:- 1432-0851
- Adenocarcinoma -- drug therapy
- Adenocarcinoma of Lung
- Aged
- Antibodies, Neutralizing -- pharmacology
- CD3 Complex -- immunology
- Carcinoma, Squamous Cell -- immunology
- Cells, Cultured
- Cohort Studies
- Combined Modality Therapy -- methods
- Female
- Humans
- Immunotherapy, Adoptive -- methods
- Interleukin-2 -- pharmacology
- Lung Neoplasms -- drug therapy
- Lymphocyte Activation -- drug effects
- Male
- Middle Aged
- Severity of Illness Index
- T-Lymphocytes -- drug effects
- Treatment Outcome
No physical items for this record
Publication Type: Controlled Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.